175 related articles for article (PubMed ID: 15036666)
1. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
Talieri M; Papadopoulou S; Scorilas A; Xynopoulos D; Arnogianaki N; Plataniotis G; Yotis J; Agnanti N
Cancer Lett; 2004 Mar; 205(1):97-106. PubMed ID: 15036666
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin B and tumor-associated laminin expression in the progression of colorectal adenoma to carcinoma.
Khan A; Krishna M; Baker SP; Banner BF
Mod Pathol; 1998 Aug; 11(8):704-8. PubMed ID: 9720496
[TBL] [Abstract][Full Text] [Related]
3. Total and lipid-bound plasma sialic acid as diagnostic markers in colorectal cancer patients: correlation with cathepsin B expression in progression to Dukes stage.
Sebzda T; Saleh Y; Gburek J; Warwas M; Andrzejak R; Siewinski M; Rudnicki J
J Exp Ther Oncol; 2006; 5(3):223-9. PubMed ID: 16528972
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Id-1 protein is a marker in colorectal cancer progression.
Zhao ZR; Zhang ZY; Zhang H; Jiang L; Wang MW; Sun XF
Oncol Rep; 2008 Feb; 19(2):419-24. PubMed ID: 18202790
[TBL] [Abstract][Full Text] [Related]
6. Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma.
Murnane MJ; Sheahan K; Ozdemirli M; Shuja S
Cancer Res; 1991 Feb; 51(4):1137-42. PubMed ID: 1997157
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin D protein levels in colorectal tumors: divergent expression patterns suggest complex regulation and function.
Iacobuzio-Donahue C; Shuja S; Cai J; Peng P; Willett J; Murnane MJ
Int J Oncol; 2004 Mar; 24(3):473-85. PubMed ID: 14767531
[TBL] [Abstract][Full Text] [Related]
8. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
9. [Expression of cathepsin B and its clinical importance in colorectal cancer].
Yu B; Li SY; An P; Zuo FY; Cai HY
Zhonghua Wei Chang Wai Ke Za Zhi; 2005 Nov; 8(6):507-9. PubMed ID: 16299652
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B on invasion and metastasis of gastric carcinoma.
Liu Y; Xiao S; Shi Y; Wang L; Ren W; Sloane BF
Chin Med J (Engl); 1998 Sep; 111(9):784-8. PubMed ID: 11155666
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic significance and clinic utility of serum and immunohistochemical cathepsin B levels in colorectal cancer].
Padilla D; Cubo T; Molina JM; García M; De la Osa G; Palomino T; Pardo R; Martín J; Arévalo E; Hernández Calvo J
An Med Interna; 2003 Oct; 20(10):521-5. PubMed ID: 14585038
[TBL] [Abstract][Full Text] [Related]
12. The expression of low density lipoprotein receptor-related protein in colorectal carcinoma.
Obermeyer K; Krueger S; Peters B; Falkenberg B; Roessner A; Röcken C
Oncol Rep; 2007 Feb; 17(2):361-7. PubMed ID: 17203175
[TBL] [Abstract][Full Text] [Related]
13. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin D expression in human colorectal cancer: relationship with tumour type and tissue differentiation grade.
Sebzda T; Saleh Y; Gburek J; Andrzejak R; Gnus J; Siewinski M; Grzebieniak Z
J Exp Ther Oncol; 2005; 5(2):145-50. PubMed ID: 16471040
[TBL] [Abstract][Full Text] [Related]
15. Maspin expression was involved in colorectal adenoma-adenocarcinoma sequence and liver metastasis of tumors.
Zheng H; Tsuneyama K; Cheng C; Takahashi H; Cui Z; Murai Y; Nomoto K; Takano Y
Anticancer Res; 2007; 27(1A):259-65. PubMed ID: 17352241
[TBL] [Abstract][Full Text] [Related]
16. Expression of cathepsin D in urothelial carcinoma of the urinary bladder: an immunohistochemical study including correlations with extracellular matrix components, CD44, p53, Rb, c-erbB-2 and the proliferation indices.
Ioachim E; Charchanti A; Stavropoulos N; Athanassiou E; Bafa M; Agnantis NJ
Anticancer Res; 2002; 22(6A):3383-8. PubMed ID: 12530091
[TBL] [Abstract][Full Text] [Related]
17. The zinc finger protein OZF (ZNF146) is overexpressed in colorectal cancer.
Ferbus D; Bovin C; Validire P; Goubin G
J Pathol; 2003 Jun; 200(2):177-82. PubMed ID: 12754738
[TBL] [Abstract][Full Text] [Related]
18. Increased TGF-beta 1 protein expression in patients with advanced colorectal cancer.
Langenskiöld M; Holmdahl L; Falk P; Angenete E; Ivarsson ML
J Surg Oncol; 2008 Apr; 97(5):409-15. PubMed ID: 18176914
[TBL] [Abstract][Full Text] [Related]
19. [Expression of tumor-associated antigen LEA and its significance for pathological diagnosis].
Feng H; Song JD
Ai Zheng; 2002 Jun; 21(6):658-62. PubMed ID: 12452070
[TBL] [Abstract][Full Text] [Related]
20. High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion.
Eiján AM; Sandes EO; Riveros MD; Thompson S; Pasik L; Mallagrino H; Celeste F; Casabé AR
Cancer; 2003 Jul; 98(2):262-8. PubMed ID: 12872343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]